# Phase1 Syudy to Evaluate the Safety and PK/PD of Human Antithrombin III

> **NCT00846274** · PHASE1 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 20 (estimated)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** SK Antithrombin III

## Key facts

- **NCT ID:** NCT00846274
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2009-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846274, "Phase1 Syudy to Evaluate the Safety and PK/PD of Human Antithrombin III". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00846274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*